Navigation Links
Veracity Logic and Medrio Announce Real Time Interface
Date:10/31/2013

Research Triangle Park, NC and San Francisco, CA (PRWEB) October 31, 2013

Veracity Logic, a provider of interactive web and voice technology solutions (IVR/IWR) for clinical trial management, and Medrio, a leading provider of Electronic Data Capture and eClinical Tools, jointly announce the completion of a real time web services interface between their two eClinical platforms.

“We are pleased to partner with Medrio in building this real time web services interface between our products. This interface will create a seamless experience for our users. When clinical data is added or updated in either the Veracity Logic VLIRT™ system or the Medrio EDC system, the two systems will stay synchronized in real time. By having users enter data in only one system, we reduce data entry errors and end-of-study data reconciliation requirements,” said David Goldston, Managing Director of Veracity Logic (VL)."

“Medrio is excited to develop this relationship with Veracity Logic given the complementary nature of our products and the benefits to our eClinical users. This interface provides better data faster and simplifies the work for our customers,” said Scott Weidley, Sr. Director of Sales and Marketing at Medrio.

About Veracity Logic
Veracity Logic is a provider of software systems for clinical study management including interactive web and voice response technology (IVR/IWR) used to manage randomization, clinical supply inventory, and subject diaries or electronic patient reported outcomes. Founded in 2005, Veracity Logic is located in Research Triangle Park, NC. Additional information on Veracity Logic is available at http://www.veracitylogic.com.

About Medrio, Inc.
Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies.Founded in 2005, Medrio is headquartered in the San Francisco Bay Area. For more information, visit http://www.medrio.com.

Read the full story at http://www.prweb.com/releases/eClinicalsoftware/eClinicaltools/prweb11278546.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
2. Breakthrough in study of aluminum should yield new technological advances
3. Samsung BioLogics unterzeichnet strategische Herstellungspartnerschaft mit Roche
4. Biosimilars Need Same Names as Original Biologics, Hospira Says at World Health Organization (WHO) Meeting
5. Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche
6. MELA Sciences, Inc., a Leader in the Fight Against Melanoma, Participates in the American Society of Dermatologic Surgery Annual Meeting
7. Elseviers Geofacets Adds More Than 80,000 Maps in Collaboration with The Geological Society of America
8. Gallus Strengthens Biologics CMO Business with Acquisition of Laureate
9. New multifunctional topological insulator material with combined superconductivity
10. Market Study MBT - The European Market for Mechanical Biological Treatment Plants
11. Synthetic Biologics Responds to Recent CDC Report on Threat of "Super Bugs"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
(Date:6/22/2016)... 2016 Research and Markets has announced the ... to their offering. The ... $29.3 billion in 2013. The market is expected to grow at ... to 2020, increasing from $50.6 billion in 2015 to $96.6 billion ... the forecast period (2015 to 2020) are discussed. As well, new ...
(Date:6/22/2016)... ... June 21, 2016 , ... New light-based technologies that facilitate a “look inside” ... to enable both compact, wearable devices for point-of-care diagnostics as well as powerful new ... Recent work and visionary future directions are detailed in a new open-access article by ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):